Search Results

CROMSOURCE, an international contract research organization, announced the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies in the pharmaceutical, biotechnology, and medical device industries, or to clients and sites directly.

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (Dialco), today announced that Dialco has engaged CROMSOURCE, a full-service Contract Research Organization (“CRO”), for its upcoming DIMI IDE usability clinical trial.

CROMSOURCE, an international contract research organization with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.

CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients.

CROMSOURCE, an international contract research organization has just opened a newly expanded office in Cary, NC.

Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced their partnership focused on improving drug development for paediatric patients.

CROMSOURCE announced today the appointment of its Regulatory Services Department Director, Mr. David R. Dills, and the expansion of its Regulatory Services portfolio.

CROMSOURCE announced a service offering and guarantee for their clients - One Trial One Price[TM].